Topic Highlight
Copyright ©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Mar 14, 2014; 20(10): 2542-2554
Published online Mar 14, 2014. doi: 10.3748/wjg.v20.i10.2542
Risk factors and outcome of bacterial infections in cirrhosis
Tony Bruns, Henning W Zimmermann, Andreas Stallmach
Tony Bruns, Andreas Stallmach, Department of Internal Medicine IV, Jena University Hospital, Friedrich Schiller University Jena, 07740 Jena, Germany
Tony Bruns, Andreas Stallmach, Integrated Research and Treatment Center - Center for Sepsis Control and Care, Jena University Hospital, Friedrich Schiller University Jena, 07740 Jena, Germany
Henning W Zimmermann, Department of Medicine III, University Hospital Aachen, 52074 Aachen, Germany
Author contributions: All authors read and approved the final version of the manuscript.
Supported by The Federal Ministry of Education and Research (BMBF) Germany (FKZ: 01 E0 1002) to Bruns T
Correspondence to: Dr. Tony Bruns, Department of Internal Medicine IV, Jena University Hospital, Friedrich Schiller University Jena, Erlanger Allee 101, 07740 Jena, Germany. tony.bruns@med.uni-jena.de
Telephone: +49-3641-9322303 Fax: +49-3641-9324222
Received: November 29, 2013
Revised: January 13, 2014
Accepted: January 20, 2014
Published online: March 14, 2014
Processing time: 102 Days and 16.4 Hours
Abstract

Viable and non-viable pathological bacterial translocation promote a self-perpetuating circle of dysfunctional immune activation and systemic inflammation facilitating infections and organ failure in advanced cirrhosis. Bacterial infections and sepsis are now recognized as a distinct stage in the natural progression of chronic liver disease as they accelerate organ failure and contribute to the high mortality observed in decompensated cirrhosis. The increasing knowledge of structural, immunological and hemodynamic pathophysiology in advanced cirrhosis has not yet translated into significantly improved outcomes of bacterial infections over the last decades. Therefore, early identification of patients at the highest risk for developing infections and infection-related complications is required to tailor the currently available measures of surveillance, prophylaxis and therapy to the patients in need in order to improve the detrimental outcome of bacterial infections in cirrhosis.

Keywords: Immunity; Infection; Cirrhosis; Chronic liver disease; Bacterial translocation; Risk factors; Mortality

Core tip: We will discuss susceptibility and impact of specific bacterial infections in cirrhosis, their natural course and the identification of risk factors for organ failure and death in order to help clinicians identifying patients at the highest risk that may benefit from intensified surveillance, prophylaxis and therapy.